齐齐哈尔医学院学报
齊齊哈爾醫學院學報
제제합이의학원학보
JOURNAL OF QIQIHAR MEDICAL COLLEGE
2014年
16期
2348-2350
,共3页
rTMS%P50%精神分裂症%感觉门控
rTMS%P50%精神分裂癥%感覺門控
rTMS%P50%정신분렬증%감각문공
rTMS%P50%Schizophrenia%Sensory gating
目的:探讨重复经颅磁刺激( rTMS)对以阴性症状为主的精神分裂症患者感觉门控P50缺陷的影响。方法30例以阴性症状为主的、采用利培酮治疗的精神分裂症患者随机分为rTMS真刺激组(研究组,15例)及rTMS伪刺激组(对照组,15例),分别接受20次rTMS治疗。治疗开始及疗程结束时测定P50,P50实验模式为听觉条件刺激(S1)测试刺激(S2)模式。并应用阴性症状量表(SANS)评定疗效。结果两组治疗后SANS评分均低于治疗前(P<0.001),且治疗后研究组评分低于对照组(P<0.001)。治疗前P50测量指标在两组患者之间差异均无统计学意义(P>0.05),治疗前后比较,两组S1潜伏期和波幅未发现明显差异(P>0.05),研究组S2潜伏期和波幅较治疗前和对照组缩短和降低(P<0.05),S2/S1比值和P50异常比率较对照组明显降低(P<0.05)。结论 rTMS结合药物治疗可以改善精神分裂症患者的阴性症状,同时改善精神分裂症的感觉门控P50抑制缺陷。
目的:探討重複經顱磁刺激( rTMS)對以陰性癥狀為主的精神分裂癥患者感覺門控P50缺陷的影響。方法30例以陰性癥狀為主的、採用利培酮治療的精神分裂癥患者隨機分為rTMS真刺激組(研究組,15例)及rTMS偽刺激組(對照組,15例),分彆接受20次rTMS治療。治療開始及療程結束時測定P50,P50實驗模式為聽覺條件刺激(S1)測試刺激(S2)模式。併應用陰性癥狀量錶(SANS)評定療效。結果兩組治療後SANS評分均低于治療前(P<0.001),且治療後研究組評分低于對照組(P<0.001)。治療前P50測量指標在兩組患者之間差異均無統計學意義(P>0.05),治療前後比較,兩組S1潛伏期和波幅未髮現明顯差異(P>0.05),研究組S2潛伏期和波幅較治療前和對照組縮短和降低(P<0.05),S2/S1比值和P50異常比率較對照組明顯降低(P<0.05)。結論 rTMS結閤藥物治療可以改善精神分裂癥患者的陰性癥狀,同時改善精神分裂癥的感覺門控P50抑製缺陷。
목적:탐토중복경로자자격( rTMS)대이음성증상위주적정신분렬증환자감각문공P50결함적영향。방법30례이음성증상위주적、채용리배동치료적정신분렬증환자수궤분위rTMS진자격조(연구조,15례)급rTMS위자격조(대조조,15례),분별접수20차rTMS치료。치료개시급료정결속시측정P50,P50실험모식위은각조건자격(S1)측시자격(S2)모식。병응용음성증상량표(SANS)평정료효。결과량조치료후SANS평분균저우치료전(P<0.001),차치료후연구조평분저우대조조(P<0.001)。치료전P50측량지표재량조환자지간차이균무통계학의의(P>0.05),치료전후비교,량조S1잠복기화파폭미발현명현차이(P>0.05),연구조S2잠복기화파폭교치료전화대조조축단화강저(P<0.05),S2/S1비치화P50이상비솔교대조조명현강저(P<0.05)。결론 rTMS결합약물치료가이개선정신분렬증환자적음성증상,동시개선정신분렬증적감각문공P50억제결함。
Objective To explore the effect of repetitive transcranial magnetic stimulation ( rTMS) on sensory gating P50 deficit in schizophrenia patients that characterized with negative symptoms .Methods 30 schizophrenia patients with predominant negative symptoms and received risperidone treatment were randomly divided into two groups-real rTMS treatment group ( research group , n =15 ) and sham rTMS treatment group (control group, n=15).Each patient in the research group received 20 rTMS sessions over 4weeks that delivered theta burst stimulation ( TBS ) to the left dorsolateral prefrontal cortex .All patients fulfilled the evaluation of sensory gating (SG) P50 with the conditioning (S1)-testing (S2) paradigm before rTMS treatment and 4 weeks after treatment.Efficacy was evaluated blindly using the Scale for the Assessment of Negative Symptoms (SANS). Results 4 weeks after treatment , the SANS scores were reduced remarkably than those before treatment in both two group, and the scores in research group was lower than that in control group (P<0.001).There was no significant difference in P50 parameters between the two groups before treatment ( P >0.05).No significant difference was found in S 1 latency and amplitude between the two groups after treatment .The S2 amplitude and latency, the S2/S1 ratio and percentage of abnormal P50 in research group were lower than control (P<0.05). Conclusions rTMS combined with medicine treatment could improve the negative symptoms and the deficit in SG P50 nhibition of schizophrenia .